Protalix BioTherapeutics (PLX) Cash from Operations (2010 - 2026)
Protalix BioTherapeutics' quarterly Cash from Operations came in at 22025000.0 in Q1 2026, up 535.45% year-on-year from 3466054.26 in Q1 2025, and up 984.98% quarter-over-quarter from 2030000.0 in Q4 2025.
Protalix BioTherapeutics has reported Cash from Operations for 17 years, with the latest figure at 22025000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 535.45% year-over-year to 22025000.0; the trailing twelve-month figure through Mar 2026 stood at 15090000.0 (up 2738.11% YoY), and the FY2025 full-year result was 11993000.0, down 238.26% from the prior year.
- Cash from Operations for Q1 2026 stood at 22025000.0, up from 2030000.0 in the prior quarter.
- The five-year high for Cash from Operations was 22025000.0 in Q1 2026, with the low at 9204000.0 in Q3 2022.
- Average Cash from Operations over 5 years is 447764.71, with a median of 2998000.0 recorded in 2023.
- Year-over-year, Cash from Operations plunged 389.57% in 2022 and surged 535.45% in 2026.
- Tracing PLX's Cash from Operations over 5 years: stood at 2611000.0 in 2022, then jumped by 237.69% to 3595000.0 in 2023, then advanced by 11.02% to 3991000.0 in 2024, then tumbled by 49.14% to 2030000.0 in 2025, then soared by 984.98% to 22025000.0 in 2026.
- The last three Cash from Operations figures came in at 22025000.0 (Q1 2026), 2030000.0 (Q4 2025), and 3732000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 22.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.03 Mn |
| Mar 31, 2026 | 22.03 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Sep 30, 2025 | -3.73 Mn |
| Sep 30, 2025 | -3.73 Mn |
| Jun 30, 2025 | -5.23 Mn |
| Jun 30, 2025 | -5.23 Mn |
| Mar 31, 2025 | -5.06 Mn |
| Mar 31, 2025 | -5.06 Mn |
| Dec 31, 2024 | 3.99 Mn |
| Dec 31, 2024 | 3.99 Mn |
| Sep 30, 2024 | 4.11 Mn |
| Sep 30, 2024 | 4.11 Mn |
| Jun 30, 2024 | -3.61 Mn |
| Jun 30, 2024 | -3.61 Mn |
| Mar 31, 2024 | 4.19 Mn |
| Mar 31, 2024 | 4.19 Mn |
| Dec 31, 2023 | 3.60 Mn |
| Dec 31, 2023 | 3.60 Mn |
| Sep 30, 2023 | -6.89 Mn |
| Sep 30, 2023 | -6.89 Mn |
| Jun 30, 2023 | 4.97 Mn |
| Jun 30, 2023 | 4.97 Mn |
| Mar 31, 2023 | -3.00 Mn |
| Mar 31, 2023 | -3.00 Mn |
| Dec 31, 2022 | -2.61 Mn |
| Dec 31, 2022 | -2.61 Mn |
| Sep 30, 2022 | -9.20 Mn |
| Sep 30, 2022 | -9.20 Mn |
| Jun 30, 2022 | -7.36 Mn |
| Jun 30, 2022 | -7.36 Mn |
| Mar 31, 2022 | -5.83 Mn |
| Mar 31, 2022 | -5.83 Mn |
| Dec 31, 2021 | -5.09 Mn |
| Dec 31, 2021 | -5.09 Mn |
| Sep 30, 2021 | -1.88 Mn |
| Sep 30, 2021 | -1.88 Mn |
| Jun 30, 2021 | 6.52 Mn |
| Jun 30, 2021 | 6.52 Mn |
| Mar 31, 2021 | -9.83 Mn |
| Mar 31, 2021 | -9.83 Mn |
| Dec 31, 2020 | -7.55 Mn |
| Dec 31, 2020 | -7.55 Mn |
| Sep 30, 2020 | -3.60 Mn |
| Sep 30, 2020 | -3.60 Mn |
| Jun 30, 2020 | -7.84 Mn |
| Jun 30, 2020 | -7.84 Mn |
| Mar 31, 2020 | -7.12 Mn |
| Mar 31, 2020 | -7.12 Mn |
| Dec 31, 2019 | -3.69 Mn |
| Dec 31, 2019 | -3.69 Mn |
| Sep 30, 2019 | -3.23 Mn |
| Sep 30, 2019 | -3.23 Mn |
| Jun 30, 2019 | -5.17 Mn |
| Jun 30, 2019 | -5.17 Mn |
| Mar 31, 2019 | -7.28 Mn |
| Mar 31, 2019 | -7.28 Mn |
| Dec 31, 2018 | -4.00 Mn |
| Dec 31, 2018 | -4.00 Mn |
| Sep 30, 2018 | 13.64 Mn |
| Sep 30, 2018 | 13.64 Mn |
| Jun 30, 2018 | -7.96 Mn |
| Jun 30, 2018 | -7.96 Mn |
| Mar 31, 2018 | -9.41 Mn |
| Mar 31, 2018 | -9.41 Mn |
| Dec 31, 2017 | 17.71 Mn |
| Dec 31, 2017 | 17.71 Mn |
| Sep 30, 2017 | -10.66 Mn |
| Sep 30, 2017 | -10.66 Mn |
| Jun 30, 2017 | -8.50 Mn |
| Jun 30, 2017 | -8.50 Mn |
| Mar 31, 2017 | -8.55 Mn |
| Mar 31, 2017 | -8.55 Mn |
| Dec 31, 2016 | -7.35 Mn |
| Dec 31, 2016 | -7.35 Mn |
| Sep 30, 2016 | -3.43 Mn |
| Sep 30, 2016 | -3.43 Mn |
| Jun 30, 2016 | -12.05 Mn |
| Jun 30, 2016 | -12.05 Mn |
| Mar 31, 2016 | -9.27 Mn |
| Mar 31, 2016 | -9.27 Mn |
| Dec 31, 2015 | -5.34 Mn |
| Dec 31, 2015 | -5.34 Mn |
| Sep 30, 2015 | -9.91 Mn |
| Sep 30, 2015 | -9.91 Mn |
| Jun 30, 2015 | -4.35 Mn |
| Jun 30, 2015 | -4.35 Mn |
| Mar 31, 2015 | -6.17 Mn |
| Mar 31, 2015 | -6.17 Mn |
| Mar 31, 2014 | -8.34 Mn |
| Mar 31, 2014 | -8.34 Mn |
| Dec 31, 2013 | 1.91 Mn |
| Dec 31, 2013 | 1.91 Mn |
| Sep 30, 2013 | -8.22 Mn |
| Sep 30, 2013 | -8.22 Mn |
| Jun 30, 2013 | -8.11 Mn |
| Jun 30, 2013 | -8.11 Mn |
| Mar 31, 2013 | -9.59 Mn |
| Mar 31, 2013 | -9.59 Mn |
| Dec 31, 2012 | 1.82 Mn |
| Dec 31, 2012 | 1.82 Mn |
| Sep 30, 2012 | -8.03 Mn |
| Sep 30, 2012 | -8.03 Mn |
| Jun 30, 2012 | 13.12 Mn |
| Jun 30, 2012 | 13.12 Mn |
| Mar 31, 2012 | -6.28 Mn |
| Mar 31, 2012 | -6.28 Mn |
| Dec 31, 2011 | -6.61 Mn |
| Dec 31, 2011 | -6.61 Mn |
| Sep 30, 2011 | -8.15 Mn |
| Sep 30, 2011 | -8.15 Mn |
| Jun 30, 2011 | -4.82 Mn |
| Jun 30, 2011 | -4.82 Mn |
| Mar 31, 2011 | -3.99 Mn |
| Mar 31, 2011 | -3.99 Mn |
| Dec 31, 2010 | -8.03 Mn |
| Dec 31, 2010 | -8.03 Mn |
| Sep 30, 2010 | -9.68 Mn |
| Sep 30, 2010 | -9.68 Mn |